Primary chemoprevention of breast cancer: Are the adverse effects too burdensome?

CMAJ. 2015 Jun 16;187(9):E276-E278. doi: 10.1503/cmaj.141627. Epub 2015 Mar 23.
No abstract available

MeSH terms

  • Adult
  • Aged
  • Androstadienes / adverse effects
  • Antineoplastic Agents / adverse effects*
  • Breast Neoplasms / etiology
  • Breast Neoplasms / mortality
  • Breast Neoplasms / prevention & control*
  • Chemoprevention
  • Female
  • Humans
  • Middle Aged
  • Risk Assessment
  • Tamoxifen / adverse effects

Substances

  • Androstadienes
  • Antineoplastic Agents
  • Tamoxifen
  • exemestane